FDA approves Eisai and Biogen’s Leqembi Iqlik BLA for early Alzheimer’s

The safety of the autoinjector was evaluated in more than 600 patients as part of the Clarity AD trial. Credit: Sam Moghadam on Unsplash.



  • The safety